As of 2026-05-23, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (25.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -231.9%.
The range of the Relative Valuation is (24.49) - (26.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 17.9x | 17.6x |
| Forward P/E multiples | 14.7x - 18.2x | 16.4x |
| Fair Price | (24.49) - (26.41) | (25.05) |
| Upside | -228.9% - -239.0% | -231.9% |
| Date | P/E |